Antiplatelet therapy after intracerebral haemorrhage: results from the RESTART trial

Press/Media: Research

Description

According to the follow-up results of the RESTART trial published in JAMA Neurology, antiplatelet therapy appears to be safe in patients who have suffered an intracerebral haemorrhage (ICH) and have previously taken antithrombotic therapy.

Period10 Sept 2021

Media contributions

1

Media contributions

  • TitleAntiplatelet therapy after intracerebral haemorrhage: results from the RESTART trial
    Media name/outletUnivadis
    Country/TerritoryUnited Kingdom
    Date10/09/21
    DescriptionAccording to the follow-up results of the RESTART trial published in JAMA Neurology, antiplatelet therapy appears to be safe in patients who have suffered an intracerebral haemorrhage (ICH) and have previously taken antithrombotic therapy.
    Producer/AuthorHeather Mason
    PersonsRustam Salman
View all 1
View less

Related content